Ixabepilone And Cyclophosphamide As Neoadjuvant Therapy In Her2-Negative Breast Cancer With Exploratory Oncotype Dx Assessments: A Sarah Cannon Research Institute Phase Ii Trial.
JOURNAL OF CLINICAL ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要